|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Eidos Therapeutics, Inc. (EIDX) |
|
|
$122.21 0.00 (0.00%) as of 4:30 Mon 1/25
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
11 |
|
|
|
Total
Direct Shares :
|
37,470 |
|
|
Total
Indirect Shares :
|
103,005,019 |
| |
%
Held by Insiders:
|
0.1% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Fox Jonathan C |
See Remarks |
2021-01-26 |
0 |
2020-09-17 |
377,673 |
| Turtle Cameron |
Chief Business Officer |
2021-01-26 |
0 |
2018-11-30 |
0 |
| Bridgebio Pharma Llc |
10% Owner |
2021-01-26 |
1,000 |
2019-07-03 |
24,575,501 |
| Sinha Uma |
Chief Scientific Officer |
2021-01-26 |
0 |
|
0 |
| Valle Franco |
Senior Vice President, Finance |
2021-01-12 |
0 |
2020-03-02 |
0 |
| Siu Christine |
CFO and Secretary |
2019-12-09 |
36,470 |
2018-11-30 |
0 |
| Aguiar Eric |
Director, 10% Owner |
2019-05-24 |
0 |
2019-07-03 |
24,575,501 |
| Kolchinsky Peter |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
| Shah Rajeev M. |
Director |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
| Satvat Ali J. |
Director, 10% Owner |
2018-06-22 |
0 |
2019-07-03 |
24,575,501 |
| Kumar Neil |
Chief Executive Officer, Director, 10% Owner |
2018-06-22 |
0 |
2019-07-03 |
24,575,501 |
|
|
